Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Illnesses, Multiple”

1,158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,158 results

Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Early research (Phase 1)Study completedNCT02352558
What this trial is testing

BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Sumitomo Pharma America, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Not applicableWithdrawnNCT04674163
What this trial is testing

Expression Profile of ERK5 and PKM2 Kinases in Neuroinflammatory Diseases.

Who this might be right for
Sclerosis, MultipleGuillain-Barre SyndromeInflammation
Centre Hospitalier Régional d'Orléans
Large-scale testing (Phase 3)Active Not RecruitingNCT03523858
What this trial is testing

Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis (PMS)
Hoffmann-La Roche 927
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Large-scale testing (Phase 3)Study completedNCT00869726
What this trial is testing

Patients With Secondary Progressive Multiple Sclerosis

Who this might be right for
Secondary Progressive Multiple Sclerosis
Eli Lilly and Company 596
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableStudy completedNCT01097538
What this trial is testing

Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Hicks, Audrey, Ph.D. 10
Not applicableStudy completedNCT02767388
What this trial is testing

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

Who this might be right for
Myelodysplastic SyndromeEffects of ChemotherapyMild Cognitive Impairment+6 more
University of Nebraska 45
Testing effectiveness (Phase 2)Study completedNCT00120835
What this trial is testing

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT02130635
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Dose-Response Relationship of Multiple Doses of GSK2269557 Administered as a Dry Powder to Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 64
Early research (Phase 1)WithdrawnNCT01009424
What this trial is testing

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

Who this might be right for
COPD
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT00036023
What this trial is testing

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

Who this might be right for
LymphomaBreast NeoplasmsLung Neoplasms+2 more
Amgen
Early research (Phase 1)Study completedNCT02166489
What this trial is testing

Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease

Who this might be right for
Chronic Renal FailurePolycystic Kidney Disease
Royan Institute 6
Not applicableStudy completedNCT04302974
What this trial is testing

Cohort Study on Patient Outcomes, Effectiveness and Cost-effectiveness of Intervention Programmes for DM/HT Patients

Who this might be right for
HypertensionDiabetes MellitusCardiovascular Diseases+3 more
The University of Hong Kong 100,000
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Testing effectiveness (Phase 2)Study completedNCT01068613
What this trial is testing

Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 62
Not applicableStudy completedNCT03600389
What this trial is testing

Patient Priorities Care (PPC)

Who this might be right for
Multiple Chronic Conditions
Yale University 414
Load More Results